Terms: = Liver cancer AND BRCA1, BRCAI, 672, ENSG00000012048, IRIS, BRCC1, RNF53, PSCP AND Treatment
153 results:
1. Abrogation of KLF5 sensitizes
Zhang Z; Liu Y; Xu Y; Xu Z; Jia J; Jin Y; Wang W; Liu L
Acta Biochim Biophys Sin (Shanghai); 2024 Apr; 56(4):576-585. PubMed ID: 38433576
[TBL] [Abstract] [Full Text] [Related]
2. Emerging therapeutic strategies for metastatic uveal melanoma: Targeting driver mutations.
Liu XL; Run-Hua Z; Pan JX; Li ZJ; Yu L; Li YL
Pigment Cell Melanoma Res; 2024 May; 37(3):411-425. PubMed ID: 38411373
[TBL] [Abstract] [Full Text] [Related]
3. Hepatitis B surface antigen positivity is associated with poor short- and long-term outcomes in patients with diffuse large B-cell lymphoma who received CHOP or R-CHOP.
Zhan Z; Guo W; Wan X; Wang B; Li J; Wang H; Li Z; Huang Y; Young KH; Bai O
Front Immunol; 2024; 15():1324113. PubMed ID: 38318173
[TBL] [Abstract] [Full Text] [Related]
4. [A Case of Postoperative Recurrence of Bilateral Breast cancer in Which Stable Disease Condition Was Achieved by Olaparib].
Terakawa H; Kawata C; Kurokawa Y; Ooe Y; Mohri R; Hirata M; Moriyama H; Kinoshita J; Kawashima H; Inaki N
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1414-1416. PubMed ID: 38303292
[TBL] [Abstract] [Full Text] [Related]
5. Performance of non-invasive tests for liver fibrosis resolution after bariatric surgery.
Raverdy V; Tavaglione F; Chatelain E; Caiazzo R; Saponaro C; Lassailly G; Verkindt H; Baud G; Marciniak C; Chetboun M; Oukhouya-Daoud N; Gnemmi V; Leteurtre E; Duhamel A; Philippe M; Marot G; Romeo S; Pattou F
Metabolism; 2024 Apr; 153():155790. PubMed ID: 38219973
[TBL] [Abstract] [Full Text] [Related]
6. BRCC36 Deubiquitinates HMGCR to Regulate the Interplay Between Ferroptosis and Pyroptosis.
Wang H; Shu L; Lv C; Liu N; Long Y; Peng X; Ling H; Tao T; Tang J; Cheng Y; Liu S; Xiao D; Tao Y
Adv Sci (Weinh); 2024 Mar; 11(11):e2304263. PubMed ID: 38178583
[TBL] [Abstract] [Full Text] [Related]
7. Recombinant human adenovirus p53 combined with transcatheter arterial chemoembolization for liver cancer: A meta-analysis.
Guo Y; Chen Y; Zhang Y; Xu M; Guo W; Zhang J; Ma G; Liu C; Yang J; Wu X
PLoS One; 2023; 18(12):e0295323. PubMed ID: 38127912
[TBL] [Abstract] [Full Text] [Related]
8. High intramuscular adipose tissue content associated with prognosis and postoperative complications of cancers.
Liu R; Qiu Z; Zhang L; Ma W; Zi L; Wang K; Kuang T; Zhao K; Wang W
J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2509-2519. PubMed ID: 37990969
[TBL] [Abstract] [Full Text] [Related]
9. Tumor Profiles of Late Presentation Uveal Ring Melanoma With Novel Characteristics - A Case Series.
Lim JZ; Crawford AZ; McGhee CNJ
Invest Ophthalmol Vis Sci; 2023 Oct; 64(13):44. PubMed ID: 37889509
[TBL] [Abstract] [Full Text] [Related]
10. Hepatitis B virus infection disrupts homologous recombination in hepatocellular carcinoma by stabilizing resection inhibitor ADRM1.
Zeng M; Tang Z; Ren L; Wang H; Wang X; Zhu W; Mao X; Li Z; Mo X; Chen J; Han J; Kong D; Ji J; Carr AM; Liu C
J Clin Invest; 2023 Dec; 133(23):. PubMed ID: 37815873
[TBL] [Abstract] [Full Text] [Related]
11. Targeted Molecular Profiling of Circulating Cell-Free DNA in Patients With Advanced Hepatocellular Carcinoma.
Cowzer D; White JB; Chou JF; Chen PJ; Kim TH; Khalil DN; El Dika IH; Columna K; Yaqubie A; Light JS; Shia J; Yarmohammadi H; Erinjeri JP; Wei AC; Jarnagin W; Do RKG; Solit DB; Capanu M; Shah RH; Berger MF; Abou-Alfa GK; Harding JJ
JCO Precis Oncol; 2023 Sep; 7():e2300272. PubMed ID: 37769223
[TBL] [Abstract] [Full Text] [Related]
12. The therapeutic principle of combined clearing heat and resolving toxin plus TACE on primary liver cancer: A systematic review and meta-analysis.
Wang Y; Lin W; Huang G; Nie S; Yu Q; Hou F; Zong S
J Ethnopharmacol; 2024 Jan; 319(Pt 1):117072. PubMed ID: 37625603
[TBL] [Abstract] [Full Text] [Related]
13. Development and validation of a prognostic score to identify the optimal candidate for preemptive TIPS in patients with cirrhosis and acute variceal bleeding.
Lv Y; Bai W; Zhu X; Xue H; Zhao J; Zhuge Y; Sun J; Zhang C; Ding P; Jiang Z; Zhu X; Ren W; Li Y; Zhang K; Zhang W; Li K; Wang Z; Luo B; Li X; Yang Z; Guo W; Xia D; Xie H; Pan Y; Yin Z; Fan D; Han G
Hepatology; 2024 Jan; 79(1):118-134. PubMed ID: 37594323
[TBL] [Abstract] [Full Text] [Related]
14. [A Case of Rectal Neuroendocrine Carcinoma with iris Metastasis].
Matsuo Y; Ichikawa Y; Sawada G; Takada A; Kim HM; Murakami M; Fukunaga H; Shirai S; Kondou S; Kimura H; Morita S
Gan To Kagaku Ryoho; 2023 May; 50(5):647-649. PubMed ID: 37218331
[TBL] [Abstract] [Full Text] [Related]
15. Prevalence and Risk Factors of Germline Pathogenic Variants in Pancreatic Ductal Adenocarcinoma.
Ryu KH; Park S; Chun JW; Cho E; Choi J; Lee DE; Shim H; Kim YH; Han SS; Park SJ; Woo SM; Kong SY
Cancer Res Treat; 2023 Oct; 55(4):1303-1312. PubMed ID: 37024097
[TBL] [Abstract] [Full Text] [Related]
16. Relationship between PET/CT images and KRAS gene mutations in colorectal cancer in Vietnamese patients.
Dan NV; Phuong PC; Thai PV; Nguyen NH; Loi NT; Cong BT
Eur Rev Med Pharmacol Sci; 2023 Feb; 27(4):1480-1486. PubMed ID: 36876696
[TBL] [Abstract] [Full Text] [Related]
17. iris metastasis as resistance mechanism to atezolizumab, carboplatin, and etoposide but responds to additional irinotecan and anlotinib in a small cell lung cancer patient.
Huang Z; Zhang Y
Thorac Cancer; 2023 Mar; 14(8):779-782. PubMed ID: 36747371
[TBL] [Abstract] [Full Text] [Related]
18. Resveratrol induces DNA damage-mediated cancer cell senescence through the DLC1-DYRK1A-EGFR axis.
Ma F; Ma Y; Liu K; Gao J; Li S; Sun X; Li G
Food Funct; 2023 Feb; 14(3):1484-1497. PubMed ID: 36651299
[TBL] [Abstract] [Full Text] [Related]
19. Pathologic complete response following FOLFIRINOX and olaparib treatment for hepatic metastasized pancreatic ductal adenocarcinoma with a germline BRCA mutation.
Okada K; Uemura K; Okamoto W; Sumiyoshi T; Shintakuya R; Otsuka H; Serikawa M; Ishii Y; Arihiro K; Takahashi S
Clin J Gastroenterol; 2023 Apr; 16(2):283-288. PubMed ID: 36574187
[TBL] [Abstract] [Full Text] [Related]
20. A novel immunotherapy prognostic score for patients with pretreated advanced urInary TrAct CArcinoma from the subgroup analysis of the SAUL study: the ITACA Score.
Fornarini G; Rebuzzi SE; Buti S; Rescigno P; Merseburger A; Sternberg CN; de Giorgi U; Basso U; Maruzzo M; Giannatempo P; Ponzano M; Giunta EF; Catalano F; Murianni V; Damassi A; Cremante M; Gandini A; Puglisi S; Llaja Obispo MA; Signori A; Banna GL
Minerva Urol Nephrol; 2023 Jun; 75(3):308-318. PubMed ID: 36511379
[TBL] [Abstract] [Full Text] [Related]
[Next]
